# s_type = frag
# newdoc id = AMALGUM_academic_prodigiosin
# sent_id = AMALGUM_academic_prodigiosin-1
# text = 1. Introduction
1	1.	1.	X	LS	_	2	dep	2:dep	Discourse=preparation:1->5
2	Introduction	introduction	NOUN	NN	Number=Sing	0	root	0:root	Entity=(abstract-1)

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-2
# text = Cancer has been a major threat to human health in recent years .
1	Cancer	Cancer	PROPN	NNP	Number=Sing	6	nsubj	6:nsubj	Discourse=background:2->5|Entity=(abstract-2)
2	has	have	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	6	aux	6:aux	_
3	been	be	AUX	VBN	Tense=Past|VerbForm=Part	6	cop	6:cop	_
4	a	a	DET	DT	Definite=Ind|PronType=Art	6	det	6:det	Entity=(abstract-2
5	major	major	ADJ	JJ	Degree=Pos	6	amod	6:amod	_
6	threat	threat	NOUN	NN	Number=Sing	0	root	0:root	_
7	to	to	ADP	IN	_	9	case	9:case	_
8	human	human	ADJ	JJ	Degree=Pos	9	amod	9:amod	Entity=(abstract-3
9	health	health	NOUN	NN	Number=Sing	6	nmod	6:nmod:to	Entity=abstract-3)
10	in	in	ADP	IN	_	12	case	12:case	_
11	recent	recent	ADJ	JJ	Degree=Pos	12	amod	12:amod	Entity=(time-4
12	years	year	NOUN	NNS	Number=Plur	6	nmod	6:nmod:in	Entity=abstract-2)time-4)
13	.	.	PUNCT	.	_	6	punct	6:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-3
# text = In the past forty years , even though great efforts have been made , there is still much to be done before a safe therapy is achieved .
1	In	in	ADP	IN	_	5	case	5:case	Discourse=preparation:3->5
2	the	the	DET	DT	Definite=Def|PronType=Art	5	det	5:det	Entity=(time-4
3	past	past	ADJ	JJ	Degree=Pos	5	amod	5:amod	_
4	forty	40	NUM	CD	NumForm=Digit|NumType=Card	5	nummod	5:nummod	_
5	years	year	NOUN	NNS	Number=Plur	16	obl	16:obl:in	Entity=time-4)
6	,	,	PUNCT	,	_	5	punct	5:punct	_
7	even	even	ADV	RB	_	13	advmod	13:advmod	Discourse=concession:4->5
8	though	though	SCONJ	IN	_	13	mark	13:mark	_
9	great	great	ADJ	JJ	Degree=Pos	10	amod	10:amod	Entity=(event-5
10	efforts	effort	NOUN	NNS	Number=Plur	13	nsubj:pass	13:nsubj:pass	Entity=event-5)
11	have	have	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	13	aux	13:aux	_
12	been	be	AUX	VBN	Tense=Past|VerbForm=Part	13	aux:pass	13:aux:pass	_
13	made	make	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	16	advcl	16:advcl:though	_
14	,	,	PUNCT	,	_	13	punct	13:punct	_
15	there	there	PRON	EX	_	16	expl	16:expl	Discourse=ROOT:5
16	is	be	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
17	still	still	ADV	RB	Degree=Pos	16	advmod	16:advmod	_
18	much	much	ADJ	JJ	Degree=Pos	16	nsubj	16:nsubj	_
19	to	to	PART	TO	_	21	mark	21:mark	Discourse=elaboration:6->5
20	be	be	AUX	VB	VerbForm=Inf	21	aux:pass	21:aux:pass	_
21	done	do	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	18	acl	18:acl:to	_
22	before	before	SCONJ	IN	_	27	mark	27:mark	Discourse=circumstance:7->5
23	a	a	DET	DT	Definite=Ind|PronType=Art	25	det	25:det	Entity=(event-6
24	safe	safe	ADJ	JJ	Degree=Pos	25	amod	25:amod	_
25	therapy	therapy	NOUN	NN	Number=Sing	27	nsubj:pass	27:nsubj:pass	Entity=event-6)
26	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	27	aux:pass	27:aux:pass	_
27	achieved	achieve	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	21	advcl	21:advcl:before	_
28	.	.	PUNCT	.	_	16	punct	16:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-4
# text = Currently , chemotherapy and radiotherapy are still the main therapeutic methods for cancer .
1	Currently	currently	ADV	RB	Degree=Pos	11	advmod	11:advmod	Discourse=elaboration:8->5
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	chemotherapy	chemotherapy	NOUN	NN	Number=Sing	11	nsubj	11:nsubj	Entity=(abstract-7)
4	and	and	CCONJ	CC	_	5	cc	5:cc	_
5	radiotherapy	radiotherapy	NOUN	NN	Number=Sing	3	conj	3:conj:and|11:nsubj	Entity=(abstract-8)
6	are	be	AUX	VBP	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	11	cop	11:cop	_
7	still	still	ADV	RB	Degree=Pos	11	advmod	11:advmod	Entity=(abstract-8
8	the	the	DET	DT	Definite=Def|PronType=Art	11	det	11:det	_
9	main	main	ADJ	JJ	Degree=Pos	11	amod	11:amod	_
10	therapeutic	therapeutic	ADJ	JJ	Degree=Pos	11	amod	11:amod	_
11	methods	method	NOUN	NNS	Number=Plur	0	root	0:root	_
12	for	for	ADP	IN	_	13	case	13:case	_
13	cancer	cancer	NOUN	NN	Number=Sing	11	nmod	11:nmod:for	Entity=abstract-8)(abstract-2)
14	.	.	PUNCT	.	_	11	punct	11:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-5
# text = However , most of the anticancer drugs have toxic side effects .
1	However	however	ADV	RB	_	8	advmod	8:advmod	Discourse=contrast:9->8
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	most	most	ADJ	JJS	Degree=Sup	8	nsubj	8:nsubj	Entity=(substance-9
4	of	of	ADP	IN	_	7	case	7:case	_
5	the	the	DET	DT	Definite=Def|PronType=Art	7	det	7:det	_
6	anticancer	anticancer	NOUN	NN	Number=Sing	7	compound	7:compound	Entity=(abstract-10)
7	drugs	drug	NOUN	NNS	Number=Plur	3	obl	3:obl:of	Entity=substance-9)
8	have	have	VERB	VBP	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
9	toxic	toxic	ADJ	JJ	Degree=Pos	11	amod	11:amod	Entity=(abstract-11
10	side	side	NOUN	NN	Number=Sing	11	compound	11:compound	_
11	effects	effect	NOUN	NNS	Number=Plur	8	obj	8:obj	Entity=abstract-11)
12	.	.	PUNCT	.	_	8	punct	8:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-6
# text = Therefore , it is critical to develop novel anticancer drugs that have no toxic side effects on other tissues or organs in vivo , and only target the lesion area .
1	Therefore	therefore	ADV	RB	Degree=Pos	5	advmod	5:advmod	Discourse=joint:10->9
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	it	it	PRON	PRP	Case=Nom|Gender=Neut|Number=Sing|Person=3|PronType=Prs	5	expl	5:expl	Entity=(abstract-2)
4	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	5	cop	5:cop	_
5	critical	critical	ADJ	JJ	Degree=Pos	0	root	0:root	_
6	to	to	PART	TO	_	7	mark	7:mark	_
7	develop	develop	VERB	VB	VerbForm=Inf	5	csubj	5:csubj	Entity=(event-12)
8	novel	novel	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(substance-9
9	anticancer	anticancer	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(abstract-10)
10	drugs	drug	NOUN	NNS	Number=Plur	7	obj	7:obj|12:nsubj	_
11	that	that	PRON	WDT	PronType=Rel	12	nsubj	10:ref	Discourse=elaboration:11->10
12	have	have	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	10	acl:relcl	10:acl:relcl	_
13	no	no	DET	DT	Polarity=Neg	16	det	16:det	Entity=(abstract-11
14	toxic	toxic	ADJ	JJ	Degree=Pos	16	amod	16:amod	_
15	side	side	NOUN	NN	Number=Sing	16	compound	16:compound	Entity=(abstract-13)
16	effects	effect	NOUN	NNS	Number=Plur	12	obj	12:obj	_
17	on	on	ADP	IN	_	19	case	19:case	_
18	other	other	ADJ	JJ	Degree=Pos	19	amod	19:amod	Entity=(object-14
19	tissues	tissue	NOUN	NNS	Number=Plur	16	nmod	16:nmod:on	Entity=object-14)
20	or	or	CCONJ	CC	_	21	cc	21:cc	_
21	organs	organ	NOUN	NNS	Number=Plur	19	conj	16:nmod:on|19:conj:or	Entity=(object-15
22	in	in	ADP	IN	_	23	case	23:case	_
23	vivo	vivo	NOUN	NN	Number=Sing	19	nmod	19:nmod:in	Entity=abstract-11)object-15)(abstract-16)
24	,	,	PUNCT	,	_	27	punct	27:punct	_
25	and	and	CCONJ	CC	_	27	cc	27:cc	Discourse=joint:12->10
26	only	only	ADV	RB	_	27	advmod	27:advmod	_
27	target	target	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	12	conj	10:acl:relcl|12:conj:and	_
28	the	the	DET	DT	Definite=Def|PronType=Art	30	det	30:det	Entity=(place-17
29	lesion	lesion	NOUN	NN	Number=Sing	30	compound	30:compound	Entity=(abstract-18)
30	area	area	NOUN	NN	Number=Sing	27	obj	27:obj	Entity=substance-9)place-17)
31	.	.	PUNCT	.	_	5	punct	5:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-7
# text = Compared with traditional chemotherapeutic drugs , the nano-anticancer drug therapy has potential application prospects in curing cancer diseases .
1	Compared	compare	VERB	VBN	Tense=Past|VerbForm=Part	11	advcl	11:advcl	Discourse=attribution:13->14
2	with	with	ADP	IN	_	5	case	5:case	_
3	traditional	traditional	ADJ	JJ	Degree=Pos	5	amod	5:amod	Entity=(substance-9
4	chemotherapeutic	chemotherapeutic	ADJ	JJ	Degree=Pos	5	amod	5:amod	_
5	drugs	drug	NOUN	NNS	Number=Plur	1	obl	1:obl:with	Entity=substance-9)
6	,	,	PUNCT	,	_	1	punct	1:punct	_
7	the	the	DET	DT	Definite=Def|PronType=Art	10	det	10:det	Discourse=joint:14->12|Entity=(event-6
8	nano-anticancer	nano-anticancer	ADJ	JJ	Degree=Pos	10	amod	10:amod	_
9	drug	drug	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(substance-19)
10	therapy	therapy	NOUN	NN	Number=Sing	11	nsubj	11:nsubj	Entity=event-6)
11	has	have	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
12	potential	potential	ADJ	JJ	Degree=Pos	14	amod	14:amod	Entity=(abstract-20
13	application	application	NOUN	NN	Number=Sing	14	compound	14:compound	Entity=(abstract-21)
14	prospects	prospect	NOUN	NNS	Number=Plur	11	obj	11:obj	Entity=abstract-20)
15	in	in	SCONJ	IN	_	16	mark	16:mark	Discourse=elaboration:15->14
16	curing	cure	VERB	VBG	VerbForm=Ger	11	advcl	11:advcl:in	_
17	cancer	cancer	NOUN	NN	Number=Sing	18	compound	18:compound	Entity=(abstract-22(abstract-2)
18	diseases	disease	NOUN	NNS	Number=Plur	16	obj	16:obj	Entity=abstract-22)
19	.	.	PUNCT	.	_	11	punct	11:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-8
# text = One of the major concerns about the nano-anticancer drugs is the drug-delivery vector .
1	One	one	NUM	CD	NumForm=Word|NumType=Card	13	nsubj	13:nsubj	Discourse=joint:16->14|Entity=(abstract-23
2	of	of	ADP	IN	_	5	case	5:case	_
3	the	the	DET	DT	Definite=Def|PronType=Art	5	det	5:det	Entity=(abstract-24
4	major	major	ADJ	JJ	Degree=Pos	5	amod	5:amod	_
5	concerns	concern	NOUN	NNS	Number=Plur	1	nmod	1:nmod:of	_
6	about	about	ADP	IN	_	9	case	9:case	_
7	the	the	DET	DT	Definite=Def|PronType=Art	9	det	9:det	Entity=(substance-9
8	nano-anticancer	nano-anticancer	NOUN	NN	Number=Sing	9	compound	9:compound	Entity=(abstract-25)
9	drugs	drug	NOUN	NNS	Number=Plur	5	nmod	5:nmod:about	Entity=abstract-23)abstract-24)substance-9)
10	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	13	cop	13:cop	_
11	the	the	DET	DT	Definite=Def|PronType=Art	13	det	13:det	Entity=(abstract-23
12	drug-delivery	drug-delivery	ADJ	JJ	Degree=Pos	13	amod	13:amod	_
13	vector	vector	NOUN	NN	Number=Sing	0	root	0:root	Entity=abstract-23)
14	.	.	PUNCT	.	_	13	punct	13:punct	_

# s_type = sub
# sent_id = AMALGUM_academic_prodigiosin-9
# text = The ideal delivery vector should possess such characteristics as a high drug-loading capacity , low immunogenicity , low toxicity , better shelf-life , and water solubility , and it should have the potential to be further modified .
1	The	the	DET	DT	Definite=Def|PronType=Art	4	det	4:det	Discourse=joint:17->16|Entity=(abstract-23
2	ideal	ideal	ADJ	JJ	Degree=Pos	4	amod	4:amod	_
3	delivery	delivery	NOUN	NN	Number=Sing	4	compound	4:compound	Entity=(abstract-26)
4	vector	vector	NOUN	NN	Number=Sing	6	nsubj	6:nsubj	Entity=abstract-23)
5	should	should	AUX	MD	VerbForm=Fin	6	aux	6:aux	_
6	possess	possess	VERB	VB	VerbForm=Inf	0	root	0:root	_
7	such	such	ADJ	JJ	Degree=Pos	8	amod	8:amod	Entity=(abstract-27
8	characteristics	characteristic	NOUN	NNS	Number=Plur	6	obj	6:obj	_
9	as	as	ADP	IN	_	13	case	13:case	_
10	a	a	DET	DT	Definite=Ind|PronType=Art	13	det	13:det	Entity=(abstract-28
11	high	high	ADJ	JJ	Degree=Pos	13	amod	13:amod	_
12	drug-loading	drug-loading	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(substance-29)
13	capacity	capacity	NOUN	NN	Number=Sing	8	nmod	8:nmod:as	Entity=abstract-28)
14	,	,	PUNCT	,	_	16	punct	16:punct	_
15	low	low	ADJ	JJ	Degree=Pos	16	amod	16:amod	Entity=(abstract-30
16	immunogenicity	immunogenicity	NOUN	NN	Number=Sing	13	conj	8:nmod:as|13:conj:and	Entity=abstract-30)
17	,	,	PUNCT	,	_	19	punct	19:punct	_
18	low	low	ADJ	JJ	Degree=Pos	19	amod	19:amod	Entity=(abstract-31
19	toxicity	toxicity	NOUN	NN	Number=Sing	13	conj	8:nmod:as|13:conj:and	Entity=abstract-31)
20	,	,	PUNCT	,	_	22	punct	22:punct	_
21	better	good	ADJ	JJR	Degree=Cmp	22	amod	22:amod	Entity=(abstract-32
22	shelf-life	shelf-life	NOUN	NN	Number=Sing	13	conj	8:nmod:as|13:conj:and	Entity=abstract-32)
23	,	,	PUNCT	,	_	26	punct	26:punct	_
24	and	and	CCONJ	CC	_	26	cc	26:cc	_
25	water	water	NOUN	NN	Number=Sing	26	compound	26:compound	Entity=(substance-33(substance-34)
26	solubility	solubility	NOUN	NN	Number=Sing	13	conj	8:nmod:as|13:conj:and	Entity=abstract-27)substance-33)
27	,	,	PUNCT	,	_	31	punct	31:punct	_
28	and	and	CCONJ	CC	_	31	cc	31:cc	Discourse=joint:18->17
29	it	it	PRON	PRP	Case=Nom|Gender=Neut|Number=Sing|Person=3|PronType=Prs	31	nsubj	31:nsubj	Entity=(substance-33)
30	should	should	AUX	MD	VerbForm=Fin	31	aux	31:aux	_
31	have	have	VERB	VB	VerbForm=Inf	6	conj	6:conj:and	_
32	the	the	DET	DT	Definite=Def|PronType=Art	33	det	33:det	Entity=(abstract-35
33	potential	potential	NOUN	NN	Number=Sing	31	obj	31:obj	_
34	to	to	PART	TO	_	37	mark	37:mark	Discourse=purpose:19->18
35	be	be	AUX	VB	VerbForm=Inf	37	aux:pass	37:aux:pass	_
36	further	far	ADV	RBR	Degree=Cmp	37	advmod	37:advmod	_
37	modified	modify	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	33	acl	33:acl:to	Entity=abstract-35)
38	.	.	PUNCT	.	_	6	punct	6:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-10
# text = Synthetic polymers , such as , chitosan , polyetherimide ( PEI ) , poly(lactic-co-glycolic acid ) ( PLGA ) , polyamidoamine ( PAMAM ) , and poly-l-lactic acid ( PLA ) have been widely used in gene- and drug-delivery systems .
1	Synthetic	Synthetic	ADJ	JJ	Degree=Pos	2	amod	2:amod	Discourse=joint:20->17|Entity=(substance-36
2	polymers	polymer	NOUN	NNS	Number=Plur	35	nsubj:pass	35:nsubj:pass	_
3	,	,	PUNCT	,	_	7	punct	7:punct	_
4	such	such	ADJ	JJ	Degree=Pos	7	case	7:case	_
5	as	as	ADP	IN	_	4	fixed	4:fixed	_
6	,	,	PUNCT	,	_	4	punct	4:punct	_
7	chitosan	chitosan	NOUN	NN	Number=Sing	2	nmod	2:nmod:such_as	Entity=(plant-37)
8	,	,	PUNCT	,	_	9	punct	9:punct	_
9	polyetherimide	polyetherimide	NOUN	NN	Number=Sing	7	conj	2:nmod:such_as|7:conj:and	Entity=(abstract-38)
10	(	(	PUNCT	-LRB-	_	11	punct	11:punct	Discourse=elaboration:21->20
11	PEI	PEI	PROPN	NNP	Number=Sing	7	appos	7:appos	Entity=(person-39)
12	)	)	PUNCT	-RRB-	_	11	punct	11:punct	_
13	,	,	PUNCT	,	_	15	punct	15:punct	_
14	poly(lactic-co-glycolic	poly(lactic-co-glycolic	PROPN	NNP	Number=Sing	15	compound	15:compound	Discourse=same_unit:22->20|Entity=(substance-40(abstract-41)
15	acid	acid	NOUN	NN	Number=Sing	7	conj	2:nmod:such_as|7:conj:and	Entity=substance-40)
16	)	)	PUNCT	-RRB-	_	15	punct	15:punct	_
17	(	(	PUNCT	-LRB-	_	18	punct	18:punct	Discourse=restatement:23->22
18	PLGA	PLGA	PROPN	NNP	Number=Sing	7	dep	7:dep	_
19	)	)	PUNCT	-RRB-	_	18	punct	18:punct	_
20	,	,	PUNCT	,	_	21	punct	21:punct	_
21	polyamidoamine	polyamidoamine	NOUN	NN	Number=Sing	7	conj	2:nmod:such_as|7:conj:and	Discourse=same_unit:24->22|Entity=(substance-42)
22	(	(	PUNCT	-LRB-	_	23	punct	23:punct	Discourse=elaboration:25->24
23	PAMAM	PamaM	PROPN	NNP	Number=Sing	21	appos	21:appos	Entity=(abstract-43)
24	)	)	PUNCT	-RRB-	_	23	punct	23:punct	_
25	,	,	PUNCT	,	_	28	punct	28:punct	_
26	and	and	CCONJ	CC	_	28	cc	28:cc	Discourse=joint:26->24
27	poly-l-lactic	poly-l-lactic	NOUN	NN	Number=Sing	28	compound	28:compound	Entity=(substance-44(abstract-45)
28	acid	acid	NOUN	NN	Number=Sing	7	conj	2:nmod:such_as|7:conj:and	Entity=substance-36)substance-44)
29	(	(	PUNCT	-LRB-	_	30	punct	30:punct	Discourse=restatement:27->26
30	PLA	PLA	PROPN	NNP	Number=Sing	28	appos	28:appos	Entity=(abstract-46)
31	)	)	PUNCT	-RRB-	_	30	punct	30:punct	_
32	have	have	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	35	aux	35:aux	Discourse=same_unit:28->26
33	been	be	AUX	VBN	Tense=Past|VerbForm=Part	35	aux:pass	35:aux:pass	_
34	widely	widely	ADV	RB	Degree=Pos	35	advmod	35:advmod	_
35	used	use	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
36	in	in	ADP	IN	_	40	case	40:case	_
37	gene-	gene-	NOUN	NN	Number=Sing	40	compound	40:compound	Entity=(abstract-47(abstract-48)
38	and	and	CCONJ	CC	_	39	cc	39:cc	_
39	drug-delivery	drug-delivery	NOUN	NN	Number=Sing	37	conj	37:conj:and|40:compound	Entity=(abstract-49)
40	systems	system	NOUN	NNS	Number=Plur	35	obl	35:obl:in	Entity=abstract-47)
41	.	.	PUNCT	.	_	35	punct	35:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-11
# text = However , stability of sustained-release formulations in aqueous solution , long delivery times , and low delivery efficiency are only a small part of the challenges highlighted by researchers .
1	However	however	ADV	RB	_	23	advmod	23:advmod	Discourse=joint:29->20
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	stability	stability	NOUN	NN	Number=Sing	23	nsubj	23:nsubj	Entity=(abstract-50
4	of	of	ADP	IN	_	6	case	6:case	_
5	sustained-release	sustained-release	ADJ	JJ	Degree=Pos	6	amod	6:amod	Entity=(substance-51
6	formulations	formulation	NOUN	NNS	Number=Plur	3	nmod	3:nmod:of	_
7	in	in	ADP	IN	_	9	case	9:case	_
8	aqueous	aqueous	ADJ	JJ	Degree=Pos	9	amod	9:amod	Entity=(substance-52
9	solution	solution	NOUN	NN	Number=Sing	6	nmod	6:nmod:in	Entity=substance-52)
10	,	,	PUNCT	,	_	13	punct	13:punct	_
11	long	long	ADJ	JJ	Degree=Pos	13	amod	13:amod	Entity=(time-53
12	delivery	delivery	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(abstract-26)
13	times	time	NOUN	NNS	Number=Plur	3	conj	3:conj|23:nsubj	Entity=time-53)
14	,	,	PUNCT	,	_	18	punct	18:punct	_
15	and	and	CCONJ	CC	_	18	cc	18:cc	_
16	low	low	ADJ	JJ	Degree=Pos	18	amod	18:amod	Entity=(abstract-54
17	delivery	delivery	NOUN	NN	Number=Sing	18	compound	18:compound	Entity=(abstract-26)
18	efficiency	efficiency	NOUN	NN	Number=Sing	9	conj	6:nmod:in|9:conj:and	Entity=abstract-50)substance-51)abstract-54)
19	are	be	AUX	VBP	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	23	cop	23:cop	_
20	only	only	ADV	RB	_	23	advmod	23:advmod	_
21	a	a	DET	DT	Definite=Ind|PronType=Art	23	det	23:det	_
22	small	small	ADJ	JJ	Degree=Pos	23	amod	23:amod	_
23	part	part	NOUN	NN	Number=Sing	0	root	0:root	_
24	of	of	ADP	IN	_	26	case	26:case	_
25	the	the	DET	DT	Definite=Def|PronType=Art	26	det	26:det	Entity=(abstract-55
26	challenges	challenge	NOUN	NNS	Number=Plur	23	nmod	23:nmod:of	_
27	highlighted	highlight	VERB	VBN	Tense=Past|VerbForm=Part	26	acl	26:acl	Discourse=elaboration:30->29
28	by	by	ADP	IN	_	29	case	29:case	_
29	researchers	researcher	NOUN	NNS	Number=Plur	27	obl	27:obl:by	Entity=abstract-55)(person-56)
30	.	.	PUNCT	.	_	23	punct	23:punct	_

# s_type = frag
# sent_id = AMALGUM_academic_prodigiosin-12
# text = Dendrigraft
1	Dendrigraft	Dendrigraft	PROPN	NNP	Number=Sing	0	root	0:root	Discourse=joint:31->29|Entity=(object-57)

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-13
# text = poly-l-lysines ( DGL ) have emerged as a new kind of synthetic polymer consisting of lysine and have been employed as drug- or gene-delivery carriers , due to their biodegradability and rich external amino groups that can encapsulate drugs by the emulsion crosslinking method or plasmid DNA through electric interactions .
1	poly-l-lysines	poly-l-lysine	NOUN	NNS	Number=Plur	6	nsubj	6:nsubj|20:nsubj:pass	Discourse=elaboration:32->31|Entity=(substance-58)
2	(	(	PUNCT	-LRB-	_	3	punct	3:punct	Discourse=restatement:33->32
3	DGL	DGL	PROPN	NNP	Number=Sing	1	appos	1:appos	Entity=(abstract-59)
4	)	)	PUNCT	-RRB-	_	3	punct	3:punct	_
5	have	have	AUX	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	6	aux	6:aux	Discourse=same_unit:34->32
6	emerged	emerge	VERB	VBN	Tense=Past|VerbForm=Part	0	root	0:root	_
7	as	as	ADP	IN	_	10	case	10:case	_
8	a	a	DET	DT	Definite=Ind|PronType=Art	10	det	10:det	_
9	new	new	ADJ	JJ	Degree=Pos	10	amod	10:amod	_
10	kind	kind	NOUN	NN	Number=Sing	6	obl	6:obl:as	Entity=(substance-60
11	of	of	ADP	IN	_	13	case	13:case	_
12	synthetic	synthetic	ADJ	JJ	Degree=Pos	13	amod	13:amod	_
13	polymer	polymer	NOUN	NN	Number=Sing	10	nmod	10:nmod:of	_
14	consisting	consist	VERB	VBG	VerbForm=Ger	13	acl	13:acl	Discourse=elaboration:35->34
15	of	of	ADP	IN	_	16	case	16:case	_
16	lysine	lysine	NOUN	NN	Number=Sing	14	obl	14:obl:of	Entity=substance-60)(substance-61)
17	and	and	CCONJ	CC	_	20	cc	20:cc	Discourse=joint:36->35
18	have	have	AUX	VBP	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	20	aux	20:aux	_
19	been	be	AUX	VBN	Tense=Past|VerbForm=Part	20	aux:pass	20:aux:pass	_
20	employed	employ	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	6	conj	6:conj:and	_
21	as	as	ADP	IN	_	25	case	25:case	_
22	drug-	drug-	NOUN	NN	Number=Sing	25	compound	25:compound	Entity=(abstract-62(substance-63)
23	or	or	CCONJ	CC	_	24	cc	24:cc	_
24	gene-delivery	gene-delivery	NOUN	NN	Number=Sing	22	conj	22:conj:or|25:compound	Entity=(abstract-64)
25	carriers	carry	NOUN	NNS	Number=Plur	20	obl	20:obl:as	Entity=abstract-62)
26	,	,	PUNCT	,	_	30	punct	30:punct	_
27	due	due	ADJ	JJ	Degree=Pos	30	case	30:case	Discourse=cause:37->36
28	to	to	ADP	IN	_	27	fixed	27:fixed	_
29	their	their	PRON	PRP$	Number=Plur|Person=3|Poss=Yes|PronType=Prs	30	nmod:poss	30:nmod:poss	Entity=(abstract-65(abstract-62)
30	biodegradability	biodegradability	NOUN	NN	Number=Sing	20	obl	20:obl:due_to|38:nsubj	Entity=abstract-65)
31	and	and	CCONJ	CC	_	35	cc	35:cc	_
32	rich	rich	ADJ	JJ	Degree=Pos	35	amod	35:amod	Entity=(person-66
33	external	external	ADJ	JJ	Degree=Pos	35	amod	35:amod	_
34	amino	amino	NOUN	NN	Number=Sing	35	compound	35:compound	Entity=(object-67)
35	groups	group	NOUN	NNS	Number=Plur	30	conj	20:obl:due_to|30:conj:and	_
36	that	that	PRON	WDT	PronType=Rel	38	nsubj	30:ref	Discourse=elaboration:38->37
37	can	can	AUX	MD	VerbForm=Fin	38	aux	38:aux	_
38	encapsulate	encapsulate	VERB	VB	VerbForm=Inf	30	acl:relcl	30:acl:relcl	_
39	drugs	drug	NOUN	NNS	Number=Plur	38	obj	38:obj	Entity=(substance-9)
40	by	by	ADP	IN	_	44	case	44:case	_
41	the	the	DET	DT	Definite=Def|PronType=Art	44	det	44:det	Entity=(abstract-68
42	emulsion	emulsion	NOUN	NN	Number=Sing	44	compound	44:compound	Entity=(event-69)
43	crosslinking	crosslinking	NOUN	NN	Number=Sing	44	compound	44:compound	Entity=(event-70)
44	method	method	NOUN	NN	Number=Sing	38	obl	38:obl:by	Entity=abstract-68)
45	or	or	CCONJ	CC	_	47	cc	47:cc	_
46	plasmid	plasmid	NOUN	NN	Number=Sing	47	compound	47:compound	Entity=(abstract-71(object-72)
47	DNA	DNA	NOUN	NN	Abbr=Yes|Number=Sing	44	conj	38:obl:by|44:conj:or	Entity=abstract-71)
48	through	through	ADP	IN	_	50	case	50:case	_
49	electric	electric	ADJ	JJ	Degree=Pos	50	amod	50:amod	Entity=(event-73
50	interactions	interaction	NOUN	NNS	Number=Plur	38	obl	38:obl:through	Entity=person-66)event-73)
51	.	.	PUNCT	.	_	6	punct	6:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-14
# text = Besides their biodegradability , they can also be modified with targeting ligands and polyethylene glycol ( PEG ) , thereby rendering vectors with targeting properties and long circulation .
1	Besides	besides	ADP	IN	_	3	case	3:case	Discourse=elaboration:39->32
2	their	their	PRON	PRP$	Number=Plur|Person=3|Poss=Yes|PronType=Prs	3	nmod:poss	3:nmod:poss	Entity=(abstract-65(person-66)
3	biodegradability	biodegradability	NOUN	NN	Number=Sing	9	obl	9:obl:besides	Entity=abstract-65)
4	,	,	PUNCT	,	_	3	punct	3:punct	_
5	they	they	PRON	PRP	Case=Nom|Number=Plur|Person=3|PronType=Prs	9	nsubj:pass	9:nsubj:pass	Discourse=joint:40->39|Entity=(person-66)
6	can	can	AUX	MD	VerbForm=Fin	9	aux	9:aux	_
7	also	also	ADV	RB	_	9	advmod	9:advmod	_
8	be	be	AUX	VB	VerbForm=Inf	9	aux:pass	9:aux:pass	_
9	modified	modify	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
10	with	with	ADP	IN	_	12	case	12:case	_
11	targeting	target	VERB	VBG	VerbForm=Ger	12	amod	12:amod	Entity=(substance-74
12	ligands	ligand	NOUN	NNS	Number=Plur	9	obl	9:obl:with	Entity=substance-74)
13	and	and	CCONJ	CC	_	15	cc	15:cc	_
14	polyethylene	polyethylene	NOUN	NN	Number=Sing	15	compound	15:compound	Entity=(substance-75(substance-76)
15	glycol	glycol	NOUN	NN	Number=Sing	12	conj	9:obl:with|12:conj:and	Entity=substance-75)
16	(	(	PUNCT	-LRB-	_	17	punct	17:punct	Discourse=elaboration:41->40
17	PEG	PEG	NOUN	NN	Number=Sing	15	appos	15:appos	Entity=(object-77)
18	)	)	PUNCT	-RRB-	_	17	punct	17:punct	_
19	,	,	PUNCT	,	_	21	punct	21:punct	_
20	thereby	thereby	ADV	RB	Degree=Pos	21	advmod	21:advmod	Discourse=same_unit:42->40
21	rendering	render	VERB	VBG	VerbForm=Ger	9	advcl	9:advcl	_
22	vectors	vector	NOUN	NNS	Number=Plur	21	obj	21:obj	Entity=(object-78)
23	with	with	ADP	IN	_	25	case	25:case	_
24	targeting	targeting	NOUN	NN	Number=Sing	25	compound	25:compound	Entity=(abstract-79
25	properties	property	NOUN	NNS	Number=Plur	21	obl	21:obl:with	Entity=abstract-79)
26	and	and	CCONJ	CC	_	28	cc	28:cc	_
27	long	long	ADJ	JJ	Degree=Pos	28	amod	28:amod	Entity=(abstract-80
28	circulation	circulation	NOUN	NN	Number=Sing	25	conj	21:obl:with|25:conj:and	Entity=abstract-80)
29	.	.	PUNCT	.	_	9	punct	9:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-15
# text = As yet , there are only a few ways available for targeted delivery of anticancer drugs .
1	As	as	ADV	RB	_	2	advmod	2:advmod	Discourse=joint:43->31
2	yet	yet	ADV	RB	_	5	advmod	5:advmod	_
3	,	,	PUNCT	,	_	2	punct	2:punct	_
4	there	there	PRON	EX	_	5	expl	5:expl	_
5	are	be	VERB	VBP	Mood=Ind|Number=Plur|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
6	only	only	ADV	RB	_	9	advmod	9:advmod	Entity=(abstract-81
7	a	a	DET	DT	Definite=Ind|PronType=Art	9	det	9:det	_
8	few	few	ADJ	JJ	Degree=Pos	9	amod	9:amod	_
9	ways	way	NOUN	NNS	Number=Plur	5	nsubj	5:nsubj	_
10	available	available	ADJ	JJ	Degree=Pos	9	amod	9:amod	Discourse=elaboration:44->43|Entity=abstract-81)
11	for	for	ADP	IN	_	13	case	13:case	_
12	targeted	target	VERB	VBN	Tense=Past|VerbForm=Part	13	amod	13:amod	Entity=(abstract-26
13	delivery	delivery	NOUN	NN	Number=Sing	10	obl	10:obl:for	_
14	of	of	ADP	IN	_	16	case	16:case	_
15	anticancer	anticancer	NOUN	NN	Number=Sing	16	compound	16:compound	Entity=(substance-9(abstract-10)
16	drugs	drug	NOUN	NNS	Number=Plur	13	nmod	13:nmod:of	Entity=abstract-26)substance-9)
17	.	.	PUNCT	.	_	5	punct	5:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-16
# text = Recently , a report showed that VAR2CSA , which is exposed on the membrane of Plasmodium falciparum infected red blood cells ( iRBC ) , could bind to 90 % of tumors , which was verified by running immunohistochemistry on a tumor-tissue array .
1	Recently	recently	ADV	RB	Degree=Pos	5	advmod	5:advmod	Discourse=attribution:45->46
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	a	a	DET	DT	Definite=Ind|PronType=Art	4	det	4:det	Entity=(abstract-82
4	report	report	NOUN	NN	Number=Sing	5	nsubj	5:nsubj	Entity=abstract-82)
5	showed	show	VERB	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	0	root	0:root	_
6	that	that	SCONJ	IN	_	27	mark	27:mark	Discourse=joint:46->43
7	VAR2CSA	VAR2CSA	PROPN	NNP	Number=Sing	27	nsubj	11:nsubj:pass|27:nsubj	Entity=(abstract-83
8	,	,	PUNCT	,	_	11	punct	11:punct	_
9	which	which	PRON	WDT	PronType=Rel	11	nsubj:pass	7:ref	Discourse=elaboration:47->46
10	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	11	aux:pass	11:aux:pass	_
11	exposed	expose	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	7	acl:relcl	7:acl:relcl	_
12	on	on	ADP	IN	_	14	case	14:case	_
13	the	the	DET	DT	Definite=Def|PronType=Art	14	det	14:det	Entity=(place-84
14	membrane	membrane	NOUN	NN	Number=Sing	11	obl	11:obl:on	_
15	of	of	ADP	IN	_	21	case	21:case	_
16	Plasmodium	Plasmodium	PROPN	NNP	Number=Sing	21	compound	21:compound	Entity=(plant-85(substance-86)
17	falciparum	falciparum	NOUN	NN	Number=Sing	21	compound	21:compound	Entity=(object-87)
18	infected	infect	VERB	VBN	Tense=Past|VerbForm=Part	21	amod	21:amod	_
19	red	red	ADJ	JJ	Degree=Pos	20	amod	20:amod	Entity=(substance-88
20	blood	blood	NOUN	NN	Number=Sing	21	compound	21:compound	Entity=substance-88)
21	cells	cell	NOUN	NNS	Number=Plur	14	nmod	14:nmod:of	Entity=abstract-83)place-84)plant-85)
22	(	(	PUNCT	-LRB-	_	23	punct	23:punct	Discourse=elaboration:48->47
23	iRBC	IRBC	PROPN	NNP	Number=Sing	21	appos	21:appos	Entity=(abstract-89)
24	)	)	PUNCT	-RRB-	_	23	punct	23:punct	_
25	,	,	PUNCT	,	_	7	punct	7:punct	_
26	could	could	AUX	MD	VerbForm=Fin	27	aux	27:aux	Discourse=same_unit:49->46
27	bind	bind	VERB	VB	VerbForm=Inf	5	ccomp	5:ccomp|36:nsubj:pass	_
28	to	to	ADP	IN	_	30	case	30:case	_
29	90	90	NUM	CD	NumForm=Digit|NumType=Card	30	nummod	30:nummod	Entity=(abstract-90
30	%	%	SYM	NN	Number=Sing	27	obl	27:obl:to	_
31	of	of	ADP	IN	_	32	case	32:case	_
32	tumors	tumor	NOUN	NNS	Number=Plur	30	nmod	30:nmod:of	Entity=abstract-90)(object-91)
33	,	,	PUNCT	,	_	36	punct	36:punct	_
34	which	which	PRON	WDT	PronType=Rel	36	nsubj:pass	27:ref	Discourse=elaboration:50->49
35	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	36	aux:pass	36:aux:pass	_
36	verified	verify	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	27	acl:relcl	27:acl:relcl	_
37	by	by	SCONJ	IN	_	38	mark	38:mark	Discourse=means:51->50
38	running	run	VERB	VBG	VerbForm=Ger	36	advcl	36:advcl:by	_
39	immunohistochemistry	immunohistochemistry	NOUN	NN	Number=Sing	38	obj	38:obj	Entity=(abstract-92)
40	on	on	ADP	IN	_	43	case	43:case	_
41	a	a	DET	DT	Definite=Ind|PronType=Art	43	det	43:det	Entity=(object-93
42	tumor-tissue	tumor-tissue	ADJ	JJ	Degree=Pos	43	amod	43:amod	_
43	array	array	NOUN	NN	Number=Sing	38	obl	38:obl:on	Entity=object-93)
44	.	.	PUNCT	.	_	5	punct	5:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-17
# text = Therefore , VAR2CSA is becoming an attractive target for anticancer drugs ’ development .
1	Therefore	therefore	ADV	RB	Degree=Pos	5	advmod	5:advmod	Discourse=joint:52->46
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	VAR2CSA	VAR2CSA	PROPN	NNP	Number=Sing	5	nsubj	5:nsubj|8:nsubj:xsubj	Entity=(abstract-83)
4	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	5	aux	5:aux	_
5	becoming	become	VERB	VBG	Tense=Pres|VerbForm=Part	0	root	0:root	_
6	an	a	DET	DT	Definite=Ind|PronType=Art	8	det	8:det	_
7	attractive	attractive	ADJ	JJ	Degree=Pos	8	amod	8:amod	_
8	target	target	NOUN	NN	Number=Sing	5	xcomp	5:xcomp	_
9	for	for	ADP	IN	_	13	case	13:case	_
10	anticancer	anticancer	NOUN	NN	Number=Sing	11	compound	11:compound	Entity=(event-12(substance-9(abstract-10)
11	drugs	drug	NOUN	NNS	Number=Plur	13	nmod:poss	13:nmod:poss	_
12	’	's	PART	POS	_	11	case	11:case	Entity=substance-9)
13	development	development	NOUN	NN	Number=Sing	8	nmod	8:nmod:for	Entity=event-12)
14	.	.	PUNCT	.	_	5	punct	5:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-18
# text = P. falciparum infection during pregnancy results in the sequestration of iRBC in the placenta by adhering to a distinct type of chondroitin sulfate A ( CSA ) exclusively expressed on trophoblast via VAR2CSA .
1	P.	P.	PROPN	NNP	Number=Sing	3	compound	3:compound	Discourse=joint:53->52|Entity=(event-94(place-95
2	falciparum	falciparum	NOUN	NN	Number=Sing	1	flat	1:flat	Entity=place-95)
3	infection	infection	NOUN	NN	Number=Sing	6	nsubj	6:nsubj	_
4	during	during	ADP	IN	_	5	case	5:case	_
5	pregnancy	pregnancy	NOUN	NN	Number=Sing	3	nmod	3:nmod:during	Entity=event-94)(event-96)
6	results	result	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	0	root	0:root	_
7	in	in	ADP	IN	_	9	case	9:case	_
8	the	the	DET	DT	Definite=Def|PronType=Art	9	det	9:det	Entity=(event-97
9	sequestration	sequestration	NOUN	NN	Number=Sing	6	obl	6:obl:in	_
10	of	of	ADP	IN	_	11	case	11:case	_
11	iRBC	iRBC	NOUN	NN	Number=Sing	9	nmod	9:nmod:of	Entity=(abstract-89
12	in	in	ADP	IN	_	14	case	14:case	_
13	the	the	DET	DT	Definite=Def|PronType=Art	14	det	14:det	Entity=(place-98
14	placenta	placenta	NOUN	NN	Number=Sing	11	nmod	11:nmod:in	Entity=event-97)abstract-89)place-98)
15	by	by	SCONJ	IN	_	16	mark	16:mark	Discourse=means:54->53
16	adhering	adhere	VERB	VBG	VerbForm=Ger	6	advcl	6:advcl:by	_
17	to	to	ADP	IN	_	20	case	20:case	_
18	a	a	DET	DT	Definite=Ind|PronType=Art	20	det	20:det	Entity=(abstract-99
19	distinct	distinct	ADJ	JJ	Degree=Pos	20	amod	20:amod	_
20	type	type	NOUN	NN	Number=Sing	16	obl	16:obl:to	_
21	of	of	ADP	IN	_	22	case	22:case	_
22	chondroitin	chondroitin	NOUN	NN	Number=Sing	20	nmod	20:nmod:of	Entity=(substance-100
23	sulfate	sulfate	NOUN	NN	Number=Sing	22	flat	22:flat	_
24	A	A	PROPN	NNP	Number=Sing	22	flat	22:flat	Entity=abstract-99)substance-100)
25	(	(	PUNCT	-LRB-	_	26	punct	26:punct	Discourse=restatement:55->54
26	CSA	CSA	PROPN	NNP	Number=Sing	22	appos	22:appos	Entity=(abstract-101)
27	)	)	PUNCT	-RRB-	_	26	punct	26:punct	_
28	exclusively	exclusively	ADV	RB	Degree=Pos	29	advmod	29:advmod	Discourse=same_unit:56->53
29	expressed	express	VERB	VBN	Tense=Past|VerbForm=Part	22	acl	22:acl	Discourse=elaboration:57->56
30	on	on	ADP	IN	_	31	case	31:case	_
31	trophoblast	trophoblast	NOUN	NN	Number=Sing	29	obl	29:obl:on	Entity=(animal-102)
32	via	via	ADP	IN	_	33	case	33:case	_
33	VAR2CSA	VAR2CSA	PROPN	NNP	Number=Sing	29	obl	29:obl:via	Entity=(abstract-83)
34	.	.	PUNCT	.	_	6	punct	6:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-19
# text = Short continuous regions of VAR2CSA with affinity for multiple types of CSA were defined .
1	Short	short	ADJ	JJ	Degree=Pos	3	amod	3:amod	Discourse=joint:58->53|Entity=(place-103
2	continuous	continuous	ADJ	JJ	Degree=Pos	3	amod	3:amod	_
3	regions	region	NOUN	NNS	Number=Plur	14	nsubj:pass	14:nsubj:pass	_
4	of	of	ADP	IN	_	5	case	5:case	_
5	VAR2CSA	VAR2CSA	PROPN	NNP	Number=Sing	3	nmod	3:nmod:of	Entity=(abstract-83)
6	with	with	ADP	IN	_	7	case	7:case	_
7	affinity	affinity	NOUN	NN	Number=Sing	3	nmod	3:nmod:with	Entity=(abstract-104
8	for	for	ADP	IN	_	10	case	10:case	_
9	multiple	multiple	ADJ	JJ	Degree=Pos	10	amod	10:amod	Entity=(abstract-105
10	types	type	NOUN	NNS	Number=Plur	7	nmod	7:nmod:for	_
11	of	of	ADP	IN	_	12	case	12:case	_
12	CSA	CSA	PROPN	NNP	Number=Sing	10	nmod	10:nmod:of	Entity=place-103)abstract-104)abstract-105)(abstract-101)
13	were	be	AUX	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	14	aux:pass	14:aux:pass	_
14	defined	define	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
15	.	.	PUNCT	.	_	14	punct	14:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-20
# text = A 28 amino acids placenta CSA-binding peptide ( plCSA-BP ) from the VAR2CSA region was recently tested as a guide peptide for targeted delivery of doxorubicin to choriocarcinoma .
1	A	a	DET	DT	Definite=Ind|PronType=Art	7	det	7:det	Discourse=joint:59->58|Entity=(abstract-106
2	28	28	NUM	CD	NumForm=Digit|NumType=Card	4	nummod	4:nummod	Entity=(person-107
3	amino	amino	NOUN	NN	Number=Sing	4	compound	4:compound	_
4	acids	acid	NOUN	NNS	Number=Plur	7	nsubj:pass	7:nsubj:pass	Entity=person-107)
5	placenta	placenta	NOUN	NN	Number=Sing	6	compound	6:compound	Entity=(abstract-108(place-98)
6	CSA-binding	CSA-binding	PROPN	NNP	Number=Sing	7	compound	7:compound	Entity=abstract-108)
7	peptide	peptide	NOUN	NN	Number=Sing	17	nsubj:pass	17:nsubj:pass	Entity=abstract-106)
8	(	(	PUNCT	-LRB-	_	9	punct	9:punct	Discourse=restatement:60->59
9	plCSA-BP	plCSA-BP	PROPN	NNP	Number=Sing	7	appos	7:appos	Entity=(abstract-106)
10	)	)	PUNCT	-RRB-	_	9	punct	9:punct	_
11	from	from	ADP	IN	_	14	case	14:case	Discourse=same_unit:61->59
12	the	the	DET	DT	Definite=Def|PronType=Art	14	det	14:det	Entity=(place-17
13	VAR2CSA	VAR2CSA	PROPN	NNP	Number=Sing	14	compound	14:compound	Entity=(abstract-83)
14	region	region	NOUN	NN	Number=Sing	7	nmod	7:nmod:from	Entity=place-17)
15	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	17	aux:pass	17:aux:pass	_
16	recently	recently	ADV	RB	Degree=Pos	17	advmod	17:advmod	_
17	tested	test	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
18	as	as	ADP	IN	_	21	case	21:case	_
19	a	a	DET	DT	Definite=Ind|PronType=Art	21	det	21:det	Entity=(abstract-109
20	guide	guide	NOUN	NN	Number=Sing	21	compound	21:compound	Entity=(object-110)
21	peptide	peptide	NOUN	NN	Number=Sing	17	obl	17:obl:as	_
22	for	for	ADP	IN	_	24	case	24:case	_
23	targeted	targeted	ADJ	JJ	Degree=Pos	24	amod	24:amod	Entity=(event-111
24	delivery	delivery	NOUN	NN	Number=Sing	21	nmod	21:nmod:for	_
25	of	of	ADP	IN	_	26	case	26:case	_
26	doxorubicin	doxorubicin	NOUN	NN	Number=Sing	24	nmod	24:nmod:of	Entity=(substance-112)
27	to	to	ADP	IN	_	28	case	28:case	_
28	choriocarcinoma	choriocarcinoma	NOUN	NN	Number=Sing	24	nmod	24:nmod:to	Entity=abstract-109)event-111)(abstract-113)
29	.	.	PUNCT	.	_	17	punct	17:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-21
# text = However , whether it could be used to modify the DGL and its bioactivity after the modification was not evaluated .
1	However	however	ADV	RB	_	20	advmod	20:advmod	Discourse=contrast:62->59
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	whether	whether	SCONJ	IN	_	7	mark	7:mark	_
4	it	it	PRON	PRP	Case=Nom|Gender=Neut|Number=Sing|Person=3|PronType=Prs	7	nsubj:pass	7:nsubj:pass|9:nsubj:xsubj	Entity=(event-111)
5	could	could	AUX	MD	VerbForm=Fin	7	aux	7:aux	_
6	be	be	AUX	VB	VerbForm=Inf	7	aux:pass	7:aux:pass	_
7	used	use	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	20	csubj	20:csubj	_
8	to	to	PART	TO	_	9	mark	9:mark	Discourse=purpose:63->62
9	modify	modify	VERB	VB	VerbForm=Inf	7	xcomp	7:xcomp	_
10	the	the	DET	DT	Definite=Def|PronType=Art	11	det	11:det	Entity=(abstract-59
11	DGL	DGL	PROPN	NNP	Number=Sing	9	obj	9:obj	Entity=abstract-59)
12	and	and	CCONJ	CC	_	14	cc	14:cc	_
13	its	its	PRON	PRP$	Gender=Neut|Number=Sing|Person=3|Poss=Yes|PronType=Prs	14	nmod:poss	14:nmod:poss	Entity=(substance-114(event-111)
14	bioactivity	bioactivity	NOUN	NN	Number=Sing	11	conj	9:obj|11:conj:and	_
15	after	after	ADP	IN	_	17	case	17:case	_
16	the	the	DET	DT	Definite=Def|PronType=Art	17	det	17:det	Entity=(event-115
17	modification	modification	NOUN	NN	Number=Sing	14	nmod	14:nmod:after	Entity=substance-114)event-115)
18	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	20	aux:pass	20:aux:pass	_
19	not	not	ADV	RB	Polarity=Neg	20	advmod	20:advmod	_
20	evaluated	evaluate	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
21	.	.	PUNCT	.	_	20	punct	20:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-22
# text = The immunosuppressive , antimalarial , and pro-cytotoxic bacterial prodigiosin was recently described as a potent antimetastatic and anticancer agent .
1	The	the	DET	DT	Definite=Def|PronType=Art	9	det	9:det	Discourse=joint:64->62|Entity=(animal-116
2	immunosuppressive	immunosuppressive	ADJ	JJ	Degree=Pos	9	amod	9:amod	_
3	,	,	PUNCT	,	_	4	punct	4:punct	_
4	antimalarial	antimalarial	ADJ	JJ	Degree=Pos	2	conj	2:conj:and|9:amod	_
5	,	,	PUNCT	,	_	7	punct	7:punct	_
6	and	and	CCONJ	CC	_	7	cc	7:cc	_
7	pro-cytotoxic	pro-cytotoxic	ADJ	JJ	Degree=Pos	2	conj	2:conj:and|9:amod	_
8	bacterial	bacterial	ADJ	JJ	Degree=Pos	9	amod	9:amod	_
9	prodigiosin	prodigiosin	NOUN	NN	Number=Sing	12	nsubj:pass	12:nsubj:pass	Entity=animal-116)
10	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	12	aux:pass	12:aux:pass	_
11	recently	recently	ADV	RB	Degree=Pos	12	advmod	12:advmod	_
12	described	describe	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
13	as	as	ADP	IN	_	19	case	19:case	_
14	a	a	DET	DT	Definite=Ind|PronType=Art	19	det	19:det	Entity=(substance-117
15	potent	potent	ADJ	JJ	Degree=Pos	19	amod	19:amod	_
16	antimetastatic	antimetastatic	ADJ	JJ	Degree=Pos	19	amod	19:amod	_
17	and	and	CCONJ	CC	_	18	cc	18:cc	_
18	anticancer	anticancer	ADJ	JJ	Degree=Pos	16	conj	16:conj:and|19:amod	_
19	agent	agent	NOUN	NN	Number=Sing	12	obl	12:obl:as	Entity=substance-117)
20	.	.	PUNCT	.	_	12	punct	12:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-23
# text = It can induce apoptosis in a wide range of cancer cell lines , including hematopoietic cancer , breast cancer , gastric cancer , colon cancer , lung cancer , and rat hepatocellular carcinoma cell lines , with no marked toxicity in nonmalignant cells .
1	It	it	PRON	PRP	Case=Nom|Gender=Neut|Number=Sing|Person=3|PronType=Prs	3	nsubj	3:nsubj	Discourse=joint:65->64|Entity=(substance-117)
2	can	can	AUX	MD	VerbForm=Fin	3	aux	3:aux	_
3	induce	induce	VERB	VB	VerbForm=Inf	0	root	0:root	_
4	apoptosis	apoptosis	NOUN	NN	Number=Sing	3	obj	3:obj	Entity=(abstract-118)
5	in	in	ADP	IN	_	8	case	8:case	_
6	a	a	DET	DT	Definite=Ind|PronType=Art	8	det	8:det	Entity=(abstract-119
7	wide	wide	ADJ	JJ	Degree=Pos	8	amod	8:amod	_
8	range	range	NOUN	NN	Number=Sing	3	obl	3:obl:in	_
9	of	of	ADP	IN	_	12	case	12:case	_
10	cancer	cancer	NOUN	NN	Number=Sing	12	compound	12:compound	Entity=(object-120(abstract-2)
11	cell	cell	NOUN	NN	Number=Sing	12	compound	12:compound	Entity=(place-121)
12	lines	line	NOUN	NNS	Number=Plur	8	nmod	8:nmod:of	_
13	,	,	PUNCT	,	_	16	punct	16:punct	_
14	including	include	VERB	VBG	VerbForm=Ger	16	case	16:case	Discourse=elaboration:66->65
15	hematopoietic	hematopoietic	ADJ	JJ	Degree=Pos	16	amod	16:amod	Entity=(abstract-2
16	cancer	cancer	NOUN	NN	Number=Sing	12	nmod	12:nmod:including	Entity=abstract-2)
17	,	,	PUNCT	,	_	19	punct	19:punct	_
18	breast	breast	NOUN	NN	Number=Sing	19	compound	19:compound	Entity=(abstract-2
19	cancer	cancer	NOUN	NN	Number=Sing	16	conj	12:nmod:including|16:conj:and	Entity=abstract-2)
20	,	,	PUNCT	,	_	22	punct	22:punct	_
21	gastric	gastric	ADJ	JJ	Degree=Pos	22	amod	22:amod	Entity=(abstract-2
22	cancer	cancer	NOUN	NN	Number=Sing	16	conj	12:nmod:including|16:conj:and	Entity=abstract-2)
23	,	,	PUNCT	,	_	25	punct	25:punct	_
24	colon	colon	NOUN	NN	Number=Sing	25	compound	25:compound	Entity=(abstract-2
25	cancer	cancer	NOUN	NN	Number=Sing	16	conj	12:nmod:including|16:conj:and	Entity=abstract-2)
26	,	,	PUNCT	,	_	28	punct	28:punct	_
27	lung	lung	NOUN	NN	Number=Sing	28	compound	28:compound	Entity=(abstract-2
28	cancer	cancer	NOUN	NN	Number=Sing	16	conj	12:nmod:including|16:conj:and	Entity=abstract-2)
29	,	,	PUNCT	,	_	35	punct	35:punct	_
30	and	and	CCONJ	CC	_	35	cc	35:cc	_
31	rat	rat	NOUN	NN	Number=Sing	35	compound	35:compound	Entity=(object-120(animal-122)
32	hepatocellular	hepatocellular	ADJ	JJ	Degree=Pos	33	amod	33:amod	Entity=(substance-123
33	carcinoma	carcinoma	NOUN	NN	Number=Sing	35	compound	35:compound	Entity=substance-123)
34	cell	cell	NOUN	NN	Number=Sing	35	compound	35:compound	Entity=(place-121)
35	lines	line	NOUN	NNS	Number=Plur	16	conj	12:nmod:including|16:conj:and	Entity=abstract-119)object-120)object-120)
36	,	,	PUNCT	,	_	40	punct	40:punct	_
37	with	with	ADP	IN	_	40	case	40:case	Discourse=joint:67->65
38	no	no	DET	DT	Polarity=Neg	40	det	40:det	Entity=(abstract-31
39	marked	marked	ADJ	JJ	Degree=Pos	40	amod	40:amod	_
40	toxicity	toxicity	NOUN	NN	Number=Sing	3	obl	3:obl:with	_
41	in	in	ADP	IN	_	43	case	43:case	_
42	nonmalignant	nonmalignant	ADJ	JJ	Degree=Pos	43	amod	43:amod	Entity=(plant-85
43	cells	cell	NOUN	NNS	Number=Plur	40	nmod	40:nmod:in	Entity=abstract-31)plant-85)
44	.	.	PUNCT	.	_	3	punct	3:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-24
# text = However , prodigiosin has not been reported for the treatment of choriocarcinoma yet .
1	However	however	ADV	RB	_	7	advmod	7:advmod	Discourse=elaboration:68->67
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	prodigiosin	prodigiosin	NOUN	NN	Number=Sing	7	nsubj:pass	7:nsubj:pass	Entity=(animal-116)
4	has	have	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	7	aux	7:aux	_
5	not	not	ADV	RB	Polarity=Neg	7	advmod	7:advmod	_
6	been	be	AUX	VBN	Tense=Past|VerbForm=Part	7	aux:pass	7:aux:pass	_
7	reported	report	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
8	for	for	ADP	IN	_	10	case	10:case	_
9	the	the	DET	DT	Definite=Def|PronType=Art	10	det	10:det	Entity=(abstract-124
10	treatment	treatment	NOUN	NN	Number=Sing	7	obl	7:obl:for	_
11	of	of	ADP	IN	_	12	case	12:case	_
12	choriocarcinoma	choriocarcinoma	NOUN	NN	Number=Sing	10	nmod	10:nmod:of	Entity=abstract-124)(abstract-113)
13	yet	yet	ADV	RB	_	7	advmod	7:advmod	_
14	.	.	PUNCT	.	_	7	punct	7:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-25
# text = It is selective in promoting apoptosis of malignant tumor cells , rendering prodigiosin a promising anticancer agent .
1	It	it	PRON	PRP	Case=Nom|Gender=Neut|Number=Sing|Person=3|PronType=Prs	3	nsubj	3:nsubj	Discourse=elaboration:69->68|Entity=(abstract-113)
2	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	3	cop	3:cop	_
3	selective	selective	ADJ	JJ	Degree=Pos	0	root	0:root	_
4	in	in	SCONJ	IN	_	5	mark	5:mark	Discourse=elaboration:70->69
5	promoting	promote	VERB	VBG	VerbForm=Ger	3	advcl	3:advcl:in	_
6	apoptosis	apoptosis	NOUN	NN	Number=Sing	5	obj	5:obj	Entity=(abstract-118
7	of	of	ADP	IN	_	10	case	10:case	_
8	malignant	malignant	ADJ	JJ	Degree=Pos	10	amod	10:amod	Entity=(plant-85
9	tumor	tumor	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(object-125)
10	cells	cell	NOUN	NNS	Number=Plur	6	nmod	6:nmod:of	Entity=abstract-118)plant-85)
11	,	,	PUNCT	,	_	12	punct	12:punct	_
12	rendering	render	VERB	VBG	VerbForm=Ger	3	advcl	3:advcl	Discourse=elaboration:71->70
13	prodigiosin	prodigiosin	NOUN	NN	Number=Sing	12	iobj	12:iobj	Entity=(animal-116)
14	a	a	DET	DT	Definite=Ind|PronType=Art	17	det	17:det	Entity=(substance-117
15	promising	promising	ADJ	JJ	Degree=Pos	17	amod	17:amod	_
16	anticancer	anticancer	ADJ	JJ	Degree=Pos	17	amod	17:amod	_
17	agent	agent	NOUN	NN	Number=Sing	12	xcomp	12:xcomp	Entity=substance-117)
18	.	.	PUNCT	.	_	3	punct	3:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-26
# text = The antitumor mechanism of prodigiosin is still unclear , especially in regard to newly acquired prodigiosin produced by a small number of microorganisms , including Serratia marcescens and other bacteria , such as Streptomyces griseoviridis , Serratia spp. , Zooshikellarubidus , Vibrio sp. , Actinomycetes , and Hahella chejuensis .
1	The	the	DET	DT	Definite=Def|PronType=Art	3	det	3:det	Discourse=joint:72->67|Entity=(abstract-126
2	antitumor	antitumor	NOUN	NN	Number=Sing	3	compound	3:compound	Entity=(abstract-127)
3	mechanism	mechanism	NOUN	NN	Number=Sing	8	nsubj	8:nsubj	_
4	of	of	ADP	IN	_	5	case	5:case	_
5	prodigiosin	prodigiosin	NOUN	NN	Number=Sing	3	nmod	3:nmod:of	Entity=abstract-126)(animal-116)
6	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	8	cop	8:cop	_
7	still	still	ADV	RB	Degree=Pos	8	advmod	8:advmod	_
8	unclear	unclear	ADJ	JJ	Degree=Pos|Polarity=Neg	0	root	0:root	_
9	,	,	PUNCT	,	_	12	punct	12:punct	_
10	especially	especially	ADV	RB	Degree=Pos	12	advmod	12:advmod	_
11	in	in	ADP	IN	_	12	case	12:case	_
12	regard	regard	NOUN	NN	Number=Sing	8	obl	8:obl:in	_
13	to	to	ADP	IN	_	16	case	16:case	_
14	newly	newly	ADV	RB	Degree=Pos	15	advmod	15:advmod	Entity=(animal-116
15	acquired	acquire	VERB	VBN	Tense=Past|VerbForm=Part	16	amod	16:amod	_
16	prodigiosin	prodigiosin	NOUN	NN	Number=Sing	12	nmod	12:nmod:to	_
17	produced	produce	VERB	VBN	Tense=Past|VerbForm=Part	16	acl	16:acl	Discourse=elaboration:73->72
18	by	by	ADP	IN	_	21	case	21:case	_
19	a	a	DET	DT	Definite=Ind|PronType=Art	21	det	21:det	Entity=(abstract-128
20	small	small	ADJ	JJ	Degree=Pos	21	amod	21:amod	_
21	number	number	NOUN	NN	Number=Sing	17	obl	17:obl:by	_
22	of	of	ADP	IN	_	23	case	23:case	_
23	microorganisms	microorganism	NOUN	NNS	Number=Plur	21	nmod	21:nmod:of	Entity=(abstract-129
24	,	,	PUNCT	,	_	26	punct	26:punct	_
25	including	include	VERB	VBG	VerbForm=Ger	26	case	26:case	_
26	Serratia	Serratia	PROPN	NNP	Number=Sing	23	nmod	23:nmod:including	Entity=(abstract-130
27	marcescens	marcescen	NOUN	NNS	Number=Plur	26	flat	26:flat	_
28	and	and	CCONJ	CC	_	30	cc	30:cc	_
29	other	other	ADJ	JJ	Degree=Pos	30	amod	30:amod	Entity=(animal-131
30	bacteria	bacteria	NOUN	NNS	Number=Plur	23	conj	21:nmod:of|23:conj:and	Entity=animal-131)
31	,	,	PUNCT	,	_	35	punct	35:punct	_
32	such	such	ADJ	JJ	Degree=Pos	34	case	34:case	_
33	as	as	ADP	IN	_	32	fixed	32:fixed	_
34	Streptomyces	Streptomyces	PROPN	NNP	Number=Sing	35	compound	35:compound	Entity=(animal-132)
35	griseoviridis	griseoviridis	NOUN	NN	Number=Sing	26	flat	26:flat	_
36	,	,	PUNCT	,	_	38	punct	38:punct	_
37	Serratia	Serratia	PROPN	NNP	Number=Sing	38	compound	38:compound	Entity=(abstract-130)
38	spp.	spp.	X	FW	_	34	conj	34:conj:and|35:compound	_
39	,	,	PUNCT	,	_	40	punct	40:punct	_
40	Zooshikellarubidus	Zooshikellarubidus	PROPN	NNP	Number=Sing	34	conj	34:conj:and|35:compound	Entity=(abstract-133)
41	,	,	PUNCT	,	_	43	punct	43:punct	_
42	Vibrio	Vibrio	PROPN	NNP	Number=Sing	43	compound	43:compound	Entity=(plant-134(substance-135)
43	sp.	sp.	NOUN	NN	Number=Sing	34	conj	34:conj:and|35:compound	Entity=plant-134)
44	,	,	PUNCT	,	_	45	punct	45:punct	_
45	Actinomycetes	Actinomycetes	PROPN	NNP	Number=Sing	34	conj	34:conj:and|35:compound	Entity=(substance-136)
46	,	,	PUNCT	,	_	49	punct	49:punct	_
47	and	and	CCONJ	CC	_	49	cc	49:cc	_
48	Hahella	Hahella	PROPN	NNP	Number=Sing	49	compound	49:compound	Entity=(abstract-137(person-138)
49	chejuensis	chejuensis	NOUN	NN	Number=Sing	34	conj	34:conj:and|35:compound	Entity=animal-116)abstract-128)abstract-129)abstract-130)abstract-137)
50	.	.	PUNCT	.	_	8	punct	8:punct	_

# s_type = frag
# sent_id = AMALGUM_academic_prodigiosin-27
# text = Research on the mechanism of bacterial origin
1	Research	research	NOUN	NN	Number=Sing	0	root	0:root	Discourse=preparation:74->76|Entity=(abstract-139
2	on	on	ADP	IN	_	4	case	4:case	_
3	the	the	DET	DT	Definite=Def|PronType=Art	4	det	4:det	Entity=(abstract-140
4	mechanism	mechanism	NOUN	NN	Number=Sing	1	nmod	1:nmod:on	_
5	of	of	ADP	IN	_	7	case	7:case	_
6	bacterial	bacterial	ADJ	JJ	Degree=Pos	7	amod	7:amod	Entity=(abstract-141
7	origin	origin	NOUN	NN	Number=Sing	4	nmod	4:nmod:of	Entity=abstract-139)abstract-140)abstract-141)

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-28
# text = prodigiosin is very important for clinical application and drug development .
1	prodigiosin	prodigiosin	NOUN	NN	Number=Sing	4	nsubj	4:nsubj	Discourse=preparation:75->76|Entity=(animal-116)
2	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	4	cop	4:cop	_
3	very	very	ADV	RB	_	4	advmod	4:advmod	_
4	important	important	ADJ	JJ	Degree=Pos	0	root	0:root	_
5	for	for	ADP	IN	_	7	case	7:case	_
6	clinical	clinical	ADJ	JJ	Degree=Pos	7	amod	7:amod	Entity=(abstract-142
7	application	application	NOUN	NN	Number=Sing	4	obl	4:obl:for	Entity=abstract-142)
8	and	and	CCONJ	CC	_	10	cc	10:cc	_
9	drug	drug	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(event-12(substance-143)
10	development	development	NOUN	NN	Number=Sing	7	conj	4:obl:for|7:conj:and	Entity=event-12)
11	.	.	PUNCT	.	_	4	punct	4:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-29
# text = In this study , to develop a new type of targeted drug delivery carrier material and investigate the anticancer mechanism of prodigiosin , we first used plCSA-BP as a guide peptide to coat on the DGL vector for cancer-cell-targeted delivery of prodigiosin produced from Serratia marcescens subsp . lawsoniana HDZK-BYSB107 .
1	In	in	ADP	IN	_	3	case	3:case	Discourse=joint:76->72
2	this	this	DET	DT	Number=Sing|PronType=Dem	3	det	3:det	Entity=(abstract-144
3	study	study	NOUN	NN	Number=Sing	26	obl	26:obl:in	Entity=abstract-144)
4	,	,	PUNCT	,	_	3	punct	3:punct	_
5	to	to	PART	TO	_	6	mark	6:mark	Discourse=purpose:77->76
6	develop	develop	VERB	VB	VerbForm=Inf	26	advcl	26:advcl:to	_
7	a	a	DET	DT	Definite=Ind|PronType=Art	9	det	9:det	Entity=(abstract-145
8	new	new	ADJ	JJ	Degree=Pos	9	amod	9:amod	_
9	type	type	NOUN	NN	Number=Sing	6	obj	6:obj	_
10	of	of	ADP	IN	_	15	case	15:case	_
11	targeted	target	VERB	VBN	Tense=Past|VerbForm=Part	15	amod	15:amod	Entity=(abstract-146
12	drug	drug	NOUN	NN	Number=Sing	13	compound	13:compound	Entity=(event-111(substance-143)
13	delivery	delivery	NOUN	NN	Number=Sing	15	compound	15:compound	Entity=event-111)
14	carrier	carrier	NOUN	NN	Number=Sing	15	compound	15:compound	Entity=(organization-147)
15	material	material	NOUN	NN	Number=Sing	9	nmod	9:nmod:of	Entity=abstract-145)abstract-146)
16	and	and	CCONJ	CC	_	17	cc	17:cc	Discourse=joint:78->77
17	investigate	investigate	VERB	VB	Mood=Imp|Person=2|VerbForm=Fin	6	conj	6:conj:and|26:advcl:to	_
18	the	the	DET	DT	Definite=Def|PronType=Art	20	det	20:det	Entity=(abstract-148
19	anticancer	anticancer	ADJ	JJ	Degree=Pos	20	amod	20:amod	_
20	mechanism	mechanism	NOUN	NN	Number=Sing	17	obj	17:obj	_
21	of	of	ADP	IN	_	22	case	22:case	_
22	prodigiosin	prodigiosin	NOUN	NN	Number=Sing	20	nmod	20:nmod:of	Entity=abstract-148)(animal-116)
23	,	,	PUNCT	,	_	6	punct	6:punct	_
24	we	we	PRON	PRP	Case=Nom|Number=Plur|Person=1|PronType=Prs	26	nsubj	26:nsubj	Discourse=same_unit:79->76|Entity=(person-149)
25	first	first	ADV	RB	Degree=Pos|NumType=Ord	26	advmod	26:advmod	_
26	used	use	VERB	VBD	Mood=Ind|Number=Plur|Person=1|Tense=Past|VerbForm=Fin	0	root	0:root	_
27	plCSA-BP	plCSA-BP	PROPN	NNP	Number=Sing	26	obj	26:obj	Entity=(abstract-106)
28	as	as	ADP	IN	_	31	case	31:case	_
29	a	a	DET	DT	Definite=Ind|PronType=Art	31	det	31:det	Entity=(abstract-109
30	guide	guide	NOUN	NN	Number=Sing	31	compound	31:compound	Entity=(object-110)
31	peptide	peptide	NOUN	NN	Number=Sing	26	obl	26:obl:as	_
32	to	to	PART	TO	_	33	mark	33:mark	Discourse=purpose:80->79
33	coat	coat	VERB	VB	VerbForm=Inf	31	acl	31:acl:to	_
34	on	on	ADP	IN	_	37	case	37:case	_
35	the	the	DET	DT	Definite=Def|PronType=Art	37	det	37:det	Entity=(abstract-23
36	DGL	DGL	PROPN	NNP	Number=Sing	37	compound	37:compound	Entity=(abstract-59)
37	vector	vector	NOUN	NN	Number=Sing	33	obl	33:obl:on	Entity=abstract-23)
38	for	for	ADP	IN	_	40	case	40:case	_
39	cancer-cell-targeted	cancer-cell-targeted	ADJ	JJ	Degree=Pos	40	amod	40:amod	Entity=(abstract-150
40	delivery	delivery	NOUN	NN	Number=Sing	33	obl	33:obl:for	_
41	of	of	ADP	IN	_	42	case	42:case	_
42	prodigiosin	prodigiosin	NOUN	NN	Number=Sing	40	nmod	40:nmod:of	Entity=(animal-116
43	produced	produce	VERB	VBN	Tense=Past|VerbForm=Part	42	acl	42:acl	Discourse=elaboration:81->80
44	from	from	ADP	IN	_	46	case	46:case	_
45	Serratia	Serratia	PROPN	NNP	Number=Sing	46	compound	46:compound	Entity=(abstract-151(abstract-130)
46	marcescens	marcescen	NOUN	NNS	Number=Plur	43	obl	43:obl:from	Entity=abstract-109)abstract-150)animal-116)abstract-151)
47	subsp	subsp	NOUN	NN	Number=Sing	49	compound	49:compound	Entity=(abstract-151(plant-152)
48	.	.	PUNCT	.	_	47	punct	47:punct	_
49	lawsoniana	lawsoniana	NOUN	NN	Number=Sing	46	appos	46:appos	Entity=abstract-151)
50	HDZK-BYSB107	HDZK-BYSB107	PROPN	NNP	Number=Sing	49	dep	49:dep	Entity=(abstract-153)
51	.	.	PUNCT	.	_	26	punct	26:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-30
# text = Then , we tested the binding ability of the newly developed DGL/CSA-PNPs and its anticancer effect in vitro on a JEG3 choriocarcinoma cell line and in vivo on a tumor model , respectively .
1	Then	then	ADV	RB	PronType=Dem	4	advmod	4:advmod	Discourse=joint:82->76
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	we	we	PRON	PRP	Case=Nom|Number=Plur|Person=1|PronType=Prs	4	nsubj	4:nsubj	Entity=(person-149)
4	tested	test	VERB	VBD	Mood=Ind|Number=Plur|Person=1|Tense=Past|VerbForm=Fin	0	root	0:root	_
5	the	the	DET	DT	Definite=Def|PronType=Art	7	det	7:det	Entity=(abstract-154
6	binding	binding	NOUN	NN	Number=Sing	7	compound	7:compound	Entity=(object-155)
7	ability	ability	NOUN	NN	Number=Sing	4	obj	4:obj	_
8	of	of	ADP	IN	_	12	case	12:case	_
9	the	the	DET	DT	Definite=Def|PronType=Art	12	det	12:det	Entity=(abstract-156
10	newly	newly	ADV	RB	Degree=Pos	11	advmod	11:advmod	_
11	developed	develop	VERB	VBN	Tense=Past|VerbForm=Part	12	amod	12:amod	_
12	DGL/CSA-PNPs	DGlrcSA-PNPs	PROPN	NNP	Number=Sing	7	nmod	7:nmod:of	Entity=abstract-156)
13	and	and	CCONJ	CC	_	16	cc	16:cc	_
14	its	its	PRON	PRP$	Gender=Neut|Number=Sing|Person=3|Poss=Yes|PronType=Prs	16	nmod:poss	16:nmod:poss	Entity=(abstract-157(abstract-145)
15	anticancer	anticancer	ADJ	JJ	Degree=Pos	16	amod	16:amod	_
16	effect	effect	NOUN	NN	Number=Sing	12	conj	7:nmod:of|12:conj:and	Entity=abstract-154)abstract-157)
17	in	in	ADP	IN	_	18	case	18:case	_
18	vitro	vitro	NOUN	NN	Number=Sing	4	obl	4:obl:in	Entity=(abstract-158)
19	on	on	ADP	IN	_	24	case	24:case	_
20	a	a	DET	DT	Definite=Ind|PronType=Art	24	det	24:det	Entity=(object-159
21	JEG3	JEG3	PROPN	NNP	Number=Sing	24	compound	24:compound	Entity=(abstract-160)
22	choriocarcinoma	choriocarcinoma	NOUN	NN	Number=Sing	24	compound	24:compound	Entity=(abstract-113)
23	cell	cell	NOUN	NN	Number=Sing	24	compound	24:compound	Entity=(place-121)
24	line	line	NOUN	NN	Number=Sing	4	obl	4:obl:on	Entity=object-159)
25	and	and	CCONJ	CC	_	27	cc	27:cc	_
26	in	in	ADP	IN	_	27	case	27:case	_
27	vivo	vivo	NOUN	NN	Number=Sing	19	conj	19:conj:and|24:case	Entity=(abstract-161)
28	on	on	ADP	IN	_	31	case	31:case	_
29	a	a	DET	DT	Definite=Ind|PronType=Art	31	det	31:det	Entity=(abstract-162
30	tumor	tumor	NOUN	NN	Number=Sing	31	compound	31:compound	Entity=(object-125)
31	model	model	NOUN	NN	Number=Sing	27	orphan	27:orphan	Entity=abstract-162)
32	,	,	PUNCT	,	_	33	punct	33:punct	_
33	respectively	respectively	ADV	RB	Degree=Pos	4	advmod	4:advmod	_
34	.	.	PUNCT	.	_	4	punct	4:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-31
# text = In addition , the mechanism responsible for the anticancer effect of targeted nano-prodigiosin was also investigated .
1	In	in	ADP	IN	_	2	case	2:case	Discourse=joint:83->82
2	addition	addition	NOUN	NN	Number=Sing	16	obl	16:obl:in	_
3	,	,	PUNCT	,	_	2	punct	2:punct	_
4	the	the	DET	DT	Definite=Def|PronType=Art	5	det	5:det	Entity=(abstract-148
5	mechanism	mechanism	NOUN	NN	Number=Sing	16	nsubj:pass	16:nsubj:pass	_
6	responsible	responsible	ADJ	JJ	Degree=Pos	5	acl	5:acl	Discourse=elaboration:84->83
7	for	for	ADP	IN	_	10	case	10:case	_
8	the	the	DET	DT	Definite=Def|PronType=Art	10	det	10:det	Entity=(abstract-157
9	anticancer	anticancer	NOUN	NN	Number=Sing	10	compound	10:compound	Entity=(abstract-10)
10	effect	effect	NOUN	NN	Number=Sing	6	obl	6:obl:for	_
11	of	of	ADP	IN	_	13	case	13:case	_
12	targeted	target	VERB	VBN	Tense=Past|VerbForm=Part	13	amod	13:amod	Entity=(object-163
13	nano-prodigiosin	nano-prodigiosin	NOUN	NN	Number=Sing	10	nmod	10:nmod:of	Entity=abstract-148)abstract-157)object-163)
14	was	be	AUX	VBD	Mood=Ind|Number=Sing|Person=3|Tense=Past|VerbForm=Fin	16	aux:pass	16:aux:pass	_
15	also	also	ADV	RB	_	16	advmod	16:advmod	_
16	investigated	investigate	VERB	VBN	Tense=Past|VerbForm=Part|Voice=Pass	0	root	0:root	_
17	.	.	PUNCT	.	_	16	punct	16:punct	_

# s_type = decl
# sent_id = AMALGUM_academic_prodigiosin-32
# text = Overall , these findings suggested that the DGL/CSA vector is an excellent cancer-specific-drug delivery carrier , which has great potential as a novel delivery system for the treatment of cancer .
1	Overall	overall	ADV	RB	Degree=Pos	5	advmod	5:advmod	Discourse=attribution:85->86
2	,	,	PUNCT	,	_	1	punct	1:punct	_
3	these	this	DET	DT	Number=Plur|PronType=Dem	4	det	4:det	Entity=(abstract-164
4	findings	finding	NOUN	NNS	Number=Plur	5	nsubj	5:nsubj	Entity=abstract-164)
5	suggested	suggest	VERB	VBD	Mood=Ind|Number=Plur|Person=3|Tense=Past|VerbForm=Fin	0	root	0:root	_
6	that	that	SCONJ	IN	_	15	mark	15:mark	Discourse=joint:86->83
7	the	the	DET	DT	Definite=Def|PronType=Art	9	det	9:det	Entity=(abstract-23
8	DGL/CSA	DGL/CSA	PROPN	NNP	Number=Sing	9	compound	9:compound	Entity=(organization-165)
9	vector	vector	NOUN	NN	Number=Sing	15	nsubj	15:nsubj	Entity=abstract-23)
10	is	be	AUX	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	15	cop	15:cop	_
11	an	a	DET	DT	Definite=Ind|PronType=Art	15	det	15:det	Entity=(abstract-23
12	excellent	excellent	ADJ	JJ	Degree=Pos	15	amod	15:amod	_
13	cancer-specific-drug	cancer-specific-drug	ADJ	JJ	Degree=Pos	14	amod	14:amod	Entity=(abstract-150
14	delivery	delivery	NOUN	NN	Number=Sing	15	compound	15:compound	Entity=abstract-150)
15	carrier	carrier	NOUN	NN	Number=Sing	5	ccomp	5:ccomp|18:nsubj	_
16	,	,	PUNCT	,	_	18	punct	18:punct	_
17	which	which	PRON	WDT	PronType=Rel	18	nsubj	15:ref	Discourse=elaboration:87->86
18	has	have	VERB	VBZ	Mood=Ind|Number=Sing|Person=3|Tense=Pres|VerbForm=Fin	15	acl:relcl	15:acl:relcl	_
19	great	great	ADJ	JJ	Degree=Pos	20	amod	20:amod	Entity=(abstract-166
20	potential	potential	NOUN	NN	Number=Sing	18	obj	18:obj	Entity=abstract-166)
21	as	as	ADP	IN	_	25	case	25:case	_
22	a	a	DET	DT	Definite=Ind|PronType=Art	25	det	25:det	Entity=(abstract-167
23	novel	novel	ADJ	JJ	Degree=Pos	25	amod	25:amod	_
24	delivery	delivery	NOUN	NN	Number=Sing	25	compound	25:compound	Entity=(abstract-150)
25	system	system	NOUN	NN	Number=Sing	18	obl	18:obl:as	_
26	for	for	ADP	IN	_	28	case	28:case	_
27	the	the	DET	DT	Definite=Def|PronType=Art	28	det	28:det	Entity=(abstract-168
28	treatment	treatment	NOUN	NN	Number=Sing	25	nmod	25:nmod:for	_
29	of	of	ADP	IN	_	30	case	30:case	_
30	cancer	cancer	NOUN	NN	Number=Sing	28	nmod	28:nmod:of	Entity=abstract-23)abstract-167)abstract-168)(abstract-2)
31	.	.	PUNCT	.	_	5	punct	5:punct	_

